Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Kast

Showing results (1-10 of 175) with videos related to

Pageof 18
Sort By:
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|April 23, 2009
Trazodone generates m-CPP: in 2008 risks from m-CPP might outweigh benefits of trazodoneRichard E Kast
Cancer Biology & Therapy|September 5, 2008
Potential for all-trans retinoic acid (tretinoin) to enhance interferon-alpha treatment response in chronic myelogenous leukemia, melanoma, myeloma and renal cell carcinomaRichard E Kast
Neoplasia (New York, N.Y.)|September 6, 2007
Glioblastoma: looking at the currently marketed sigma-1 agonists and antagonistsRichard E Kast
Journal of Clinical Pharmacy and Therapeutics|November 9, 2010
Glioblastoma: synergy of growth promotion between CCL5 and NK-1R can be thwarted by blocking CCL5 with miraviroc, an FDA approved anti-HIV drug and blocking NK-1R with aprepitant, an FDA approved anti-nausea drugR E Kast
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 4, 2009
Why cerebellar glioblastoma is rare and how that indicates adjunctive use of the FDA-approved anti-emetic aprepitant might retard cerebral glioblastoma growth: a new hypothesis to an old questionRichard E Kast
Archiv Fur Geschwulstforschung|January 1, 1977
Interpretation of the common tumour antigen (CTA)--an antigen present on all human malignant tumour cells and suspected of mediating malignant growth of cellsR E Kast
Radiobiologia, Radiotherapia|January 1, 1977
Radiodiagnostic and radiotherapeutic implications of the recent discovery of a common malignant tumour antigen, CTA, absolutely unique to cancer cellsR E Kast
Leukemia Research|June 21, 2005
Evidence of a mechanism by which etanercept increased TNF-alpha in multiple myeloma: new insights into the biology of TNF-alpha giving new treatment opportunities--the role of bupropionR E Kast
Central European Neurosurgery|February 4, 2010
Glioblastoma invasion, cathepsin B, and the potential for both to be inhibited by auranofin, an old anti-rheumatoid arthritis drugR E Kast
Cancers|October 14, 2022
High Neutrophil-to-Lymphocyte Ratio Facilitates Cancer Growth-Currently Marketed Drugs Tadalafil, Isotretinoin, Colchicine, and Omega-3 to Reduce It: The TICO RegimenRichard E Kast
Pageof 18

Showing results (1-10 of 175) with videos related to

Sort By:
Pageof 18
The World Journal of Biological Psychiatry : the Official Journal of the World Federation of Societies of Biological Psychiatry|April 23, 2009
Trazodone generates m-CPP: in 2008 risks from m-CPP might outweigh benefits of trazodoneRichard E Kast
Cancer Biology & Therapy|September 5, 2008
Potential for all-trans retinoic acid (tretinoin) to enhance interferon-alpha treatment response in chronic myelogenous leukemia, melanoma, myeloma and renal cell carcinomaRichard E Kast
Neoplasia (New York, N.Y.)|September 6, 2007
Glioblastoma: looking at the currently marketed sigma-1 agonists and antagonistsRichard E Kast
Journal of Clinical Pharmacy and Therapeutics|November 9, 2010
Glioblastoma: synergy of growth promotion between CCL5 and NK-1R can be thwarted by blocking CCL5 with miraviroc, an FDA approved anti-HIV drug and blocking NK-1R with aprepitant, an FDA approved anti-nausea drugR E Kast
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|July 4, 2009
Why cerebellar glioblastoma is rare and how that indicates adjunctive use of the FDA-approved anti-emetic aprepitant might retard cerebral glioblastoma growth: a new hypothesis to an old questionRichard E Kast
Archiv Fur Geschwulstforschung|January 1, 1977
Interpretation of the common tumour antigen (CTA)--an antigen present on all human malignant tumour cells and suspected of mediating malignant growth of cellsR E Kast
Radiobiologia, Radiotherapia|January 1, 1977
Radiodiagnostic and radiotherapeutic implications of the recent discovery of a common malignant tumour antigen, CTA, absolutely unique to cancer cellsR E Kast
Leukemia Research|June 21, 2005
Evidence of a mechanism by which etanercept increased TNF-alpha in multiple myeloma: new insights into the biology of TNF-alpha giving new treatment opportunities--the role of bupropionR E Kast
Central European Neurosurgery|February 4, 2010
Glioblastoma invasion, cathepsin B, and the potential for both to be inhibited by auranofin, an old anti-rheumatoid arthritis drugR E Kast
Cancers|October 14, 2022
High Neutrophil-to-Lymphocyte Ratio Facilitates Cancer Growth-Currently Marketed Drugs Tadalafil, Isotretinoin, Colchicine, and Omega-3 to Reduce It: The TICO RegimenRichard E Kast
Pageof 18